These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 24796130)

  • 1. [Programs for continuing medical education: a session: 4. The pathogenesis and update for the treatments of Parkinson's disease].
    Hattori N
    Nihon Naika Gakkai Zasshi; 2014 Mar; 103(3):637-44. PubMed ID: 24796130
    [No Abstract]   [Full Text] [Related]  

  • 2. Drugs and drug delivery in PD: optimizing control of symptoms with pramipexole prolonged-release.
    Rascol O
    Eur J Neurol; 2011 Mar; 18 Suppl 1():3-10. PubMed ID: 21255197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pramipexole in Parkinson's disease. A short-term study using the combined levodopa-dopamine agonist test.
    Fabbrini G; Barbanti P; Aurilia C; Pauletti C; Meco G
    Funct Neurol; 2002; 17(4):199-201. PubMed ID: 12675263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective control of catatonia in Parkinson's disease by electroconvulsive therapy: a case report.
    Kamigaichi R; Kubo S; Ishikawa K; Yokoyama K; Ogaki K; Usui C; Hatta K; Arai H; Mochizuki H; Hattori N
    Eur J Neurol; 2009 Feb; 16(2):e6. PubMed ID: 19146631
    [No Abstract]   [Full Text] [Related]  

  • 5. New pharmacotherapy for Parkinson's disease.
    Gottwald MD; Bainbridge JL; Dowling GA; Aminoff MJ; Alldredge BK
    Ann Pharmacother; 1997 Oct; 31(10):1205-17. PubMed ID: 9337447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dopaminergic agonists in the treatment of Parkinson's disease].
    Supiot F; Sternon J; Zegers de Beyl D
    Rev Med Brux; 2000 Dec; 21(6):493-9. PubMed ID: 11194495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term care of Parkinson's disease. Strategies for managing "wearing off" symptom re-emergence and dyskinesias.
    Hauser RA
    Geriatrics; 2006 Sep; 61(9):14-20. PubMed ID: 16989543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Idiopathic Parkinson's disease: practical hints for the treatment].
    Ludin HP
    Praxis (Bern 1994); 2005 Jul; 94(30-31):1147-50. PubMed ID: 16117469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
    Parkinson Study Group
    JAMA; 2000 Oct; 284(15):1931-8. PubMed ID: 11035889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
    Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pramipexole. A review of its use in the management of early and advanced Parkinson's disease.
    Dooley M; Markham A
    Drugs Aging; 1998 Jun; 12(6):495-514. PubMed ID: 9638397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pramipexole ameliorates neurologic and psychiatric symptoms in a Westphal variant of Huntington's disease.
    Bonelli RM; Niederwieser G; Diez J; Gruber A; Költringer P
    Clin Neuropharmacol; 2002; 25(1):58-60. PubMed ID: 11852299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cabergoline, pramipexole and ropinirole used as monotherapy in early Parkinson's disease: an evidence-based comparison.
    Inzelberg R; Schechtman E; Nisipeanu P
    Drugs Aging; 2003; 20(11):847-55. PubMed ID: 12964891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the efficacy of pramipexole for treating levodopa-induced dyskinesia in patients with Parkinson's disease.
    Utsumi H; Okuma Y; Kano O; Suzuki Y; Iijima M; Tomimitsu H; Hashida H; Kubo S; Suzuki M; Nanri K; Matsumura M; Murakami H; Hattori N;
    Intern Med; 2013; 52(3):325-32. PubMed ID: 23370739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of severe leg oedema in a patient with Parkinson's disease treated with pramipexole.
    Cicero CE; Nicoletti A; Mostile G; Zappia M
    Postgrad Med J; 2016 Aug; 92(1090):484. PubMed ID: 26941267
    [No Abstract]   [Full Text] [Related]  

  • 16. Pramipexole versus dual release levodopa in restless legs syndrome: a double blind, randomised, cross-over trial.
    Bassetti CL; Bornatico F; Fuhr P; Schwander J; Kallweit U; Mathis J;
    Swiss Med Wkly; 2011; 141():w13274. PubMed ID: 22101745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A combined preparation stalevo in Parkinson's disease: a 5-year experience of continuous dopaminergic stimulation].
    Fedotova EIu; Karabanov AV; Poleshchuk VV; Polevaia EV; Mirkasimov AF; Zagorovskaia TB; Ivanova-Smolenskaia IA; Illarioshkin SN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(5):50-5. PubMed ID: 22951782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, safety, and tolerability of pramipexole in untreated and levodopa-treated patients with Parkinson's disease.
    Wong KS; Lu CS; Shan DE; Yang CC; Tsoi TH; Mok V
    J Neurol Sci; 2003 Dec; 216(1):81-7. PubMed ID: 14607306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
    Parkinson Study Group CALM Cohort Investigators
    Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy for patients with early-stage Parkinson's disease].
    Tanaka M; Okamoto K
    Nihon Naika Gakkai Zasshi; 2003 Aug; 92(8):1426-31. PubMed ID: 13677890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.